NOV 22, 2017 1:59 PM PST

Bi-Specific Antibodies- New Improvements to Cancer Immunotherapy

WRITTEN BY: Courtney Schaal

In the last several years, immunotherapy has been hailed as the therapeutic breakthrough for cancer that we’ve all been waiting for.  The ability to utilize and manipulate our own immune systems to eradicate cancer is not only highly promising, but has already proven effective in a subset of patients in the clinic – and this is not just in one cancer type – but many.  A lot of attention has been given to immune checkpoint blockade in highly mutagenic cancers such as melanoma and those of the lung, as well as to chimeric antigen receptor T-cell therapy (CAR-T therapy), but a third category is now gaining more attention as well.  This category is that of bispecific antibodies, or BsAbs.   Interestingly, bispecific antibodies were originally hypothesized to be a method to combat cancer as early as the 1980s.  These work through their affinity to two different targets which act to promote tumor progression.  By binding these targets, they in essence block their ability to interact with their normal partners and are then unable exert their oncogenic effects.  They also have the ability to link therapeutic agents to cancer cells to deliver the desired blow of the therapies.  This video, published by Roche in May of 2016, details the use of T-cell bispecific antibodies for use in cancer.

Sources: Roche, Youtube, Nature Reviews

 

 

 

 

About the Author
You May Also Like
JUL 15, 2022
Immunology
Pox Virus Proteins Can Launch Early Attack on Immune Defense
JUL 15, 2022
Pox Virus Proteins Can Launch Early Attack on Immune Defense
After a virus gets inside of a cell, it typically takes over the cell to produce more viral particles. But pox viruses g ...
JUL 16, 2022
Drug Discovery & Development
Whole Blood Exchange May Reduce Amyloid Plaques in Alzheimer's
JUL 16, 2022
Whole Blood Exchange May Reduce Amyloid Plaques in Alzheimer's
Whole blood exchange reduces the formation of amyloid beta plaques in mouse models of Alzheimer's disease. The corre ...
JUL 20, 2022
Microbiology
Halting the Assembly of Dangerous Paramyxoviruses Like Nipah
JUL 20, 2022
Halting the Assembly of Dangerous Paramyxoviruses Like Nipah
The paramyxovirus includes serious pathogens that can cause pandemics, including ones that lead primarily to mild. Illne ...
AUG 07, 2022
Drug Discovery & Development
Monoclonal Antibody Treatment Shows Promise in Preventing Malaria
AUG 07, 2022
Monoclonal Antibody Treatment Shows Promise in Preventing Malaria
A singular injection of a monoclonal antibody treatment candidate has been shown as safe and highly protective in US adu ...
AUG 10, 2022
Neuroscience
Memory Flash Learning Method Improves Visual Perception of People with Autism
AUG 10, 2022
Memory Flash Learning Method Improves Visual Perception of People with Autism
Tel Aviv University researchers developed a new learning method for people with autism spectrum disorder (ASD) that can ...
AUG 16, 2022
Neuroscience
Phone Therapy Shows Promise for Treating Tinnitus
AUG 16, 2022
Phone Therapy Shows Promise for Treating Tinnitus
 A phone-based therapy has shown encouraging results in treating tinnitus in a recent clinical trial. The correspon ...
Loading Comments...